PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

PCP HCV Treatment Training

Treating Hepatitis C in a Primary Care Setting

Who Should Attend
This program is directed to primary care physicians, specialists (ID, Gastro, Hepatology), nurses, public health, Drug and Alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Hepatitis C particularly people who inject drugs.

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat hcv patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.

Learning Objectives
At course completion, attendees should be able to:

Performance
Increase HCV testing, diagnosis, counseling and treatment.

Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.

Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.

Faculty Listing

Alison Kost, RN
Program Director
Community Liver Alliance

Divya Venkat, MD
Center for Inclusion Health
Allegheny Health Network

​Gina D’Aiello, PA-C
Physician Assistant, Clinical Educator

​Rebecca Altman, MPH, CRNP, FNP-BC, WHNP-BC, AAHIVM

Suzanna Masartis
CEO
Community Liver Alliance

07a6963e6b0d082f06b01ffe32d9376c

Treating Hepatitis C in a Primary Care Setting CME Provider Virtual Training Program

Program Overview
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the opioid use disorder epidemic.
Who Should Attend
This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health care workers involved in the healthcare of patients who have risk factors for Viral Hepatitis C (HCV) particularly people who use drugs.
Learning Objectives
At course completion, attendees should be able to:
Performance
Increase HCV testing, diagnosis, counseling and treatment.
Competency
Successful linkage to HCV care will increase. Providers will understand how to diagnose and treat HCV.
Increase Knowledge
Understand the effectiveness and efficacy of HCV treatment for patients and the community.
Curriculum:
• Statistics and disease burden
• Disease progression
• Extrahepatic manifestations associated with HCV
• Barriers faced by patients
• Advantages of treating in a primary care setting
• Pre-treatment assessment and evaluation
• Choosing appropriate treatment
• Preparing for treatment
• Prior authorization
• Monitoring treatment/Post-treatment monitoring
• Managing advanced and complicated disease
• Understanding drug interactions
• HBV reactivation
• Case Studies
• When to refer to specialist
• Preventing reinfection
• COVID-19 and HCV
• Understanding the role of Specialty Pharmacy/340B Specialty Pharmacy
Support:
• Participant Treatment Toolkit and resources
• Phone consultation and backup for complex cases
• Specialist referral
• Continuing education
Provider Commitment:
• Trained sites commit to sharing treatment data on a quarterly basis for 1 year via the Community Liver Alliance treatment data log.
For more information and to schedule a training program contact the Community Liver Alliance. 412-501-3CLA or Suzanna@communityliveralliance.org
Carnegie Science Center

You Make a Difference Awards Program Luncheon

The You Make a Difference Awards event is held annually to  recognize individuals and/or organizations for their outstanding accomplishments going above and beyond supporting and educating our community about liver health, disease awareness and prevention. This year we will be in person at the Carnegie Science Center, PointView Hall located in Pittsburgh, PA.  There will also be a virtual component to the event to reach our national liver community.  Tickets can be purchased via the online form below.

You can nominate a person or an organization to be considered for the 2022 You Make a Difference Award.

Industry partners must have an exhibit to attend the program. You can purchase your exhibit registration by contacting Amy Logston at amy@communityliveralliance.org.

virtual-training-1-2000x0-c-default

HCV Provider Network Meeting

In collaboration with the National Harm Reduction Coalition, the CLA convenes monthly virtual HCV Provider Networking meetings with enduring education, networking and actionable information. The HCV Provider Network reaches clinicians to educate on the importance of harm reduction services and as it relates to hepatitis C prevention and actively engages them to become advocates to inspire change. Members of the HCV Provider Network serve on the central Appalachia Viral Hepatitis Elimination Summit planning committee. HCV Provider Network members will also serve as mentors, educators and planning committee members for the Learning Lab Program. The HCV Provider Network will actively advocate to expand harm reduction services within their communities through education, activism and support. The Network will offer expert testimony to bring down statutory barriers, provide trainings and education to preserve harm reduction services, access to hepatitis C screening, treatment and linkage to care.

hepatitis-c-positive

Special Speakers Series: Treating HCV in People Inject Drugs (PWID) with Dr. Divya Venkat

The goal of this session is to help clinicians and other service providers understand the regional and national picture of HCV infection in the population of people who inject drugs. Treatment as prevention for HCV amongst PWIDs is efficacious and cost-effective. As injecting drug use is the key driver of HCV incidence, the benefit of this approach is the rapid reduction in community HCV prevalence and incidence, achieved by treating a small proportion of current PWIDs.